General Medicine and Primary Care

Host: John Russell, MD

As a young critical care physician, Dr. Rana Awdish was transfigured from a doctor into a critically ill patient in an instant. This transposition, coincidentally timed at the end of her medical training, instantly laid bare the vast chasm between the conventional practice of medicine and the stark reality of the prostrate patient.

Host Dr. John Russell chats with Dr. Rana Awdish about this transformation and how she came to understand the fatal flaws in her profession, from her own past actions as a physician to the perils of navigating her own illness. She presents a new paradigm and rationale for embracing the emotional bond between doctor and patient and outlines the redemptive possibilities of dismantling the barriers to connection in all relationships.

Dr. Awdish is the author of In Shock: My Journey from Death to Recovery and the Redemptive Power of Hope and Director of the Pulmonary Hypertension Program at Henry Ford Hospital in Detroit.

Host: John Russell, MD

Guest: Meredith Wadman, BM, BCh, M.S.

Until the late 1960s, tens of thousands of American children suffered crippling birth defects if their mothers had been exposed to rubella, popularly known as German measles, while pregnant; there was no vaccine and little understanding of how the disease devastated fetuses.

In June 1962, a young biologist in Philadelphia, using human tissue samples sent from Sweden, produced a line of cells that allowed the creation of vaccines against rubella and other common childhood diseases. Two years later, in the midst of a massive German measles epidemic, the vaccine that would one day wipe out homegrown rubella was introduced. This vaccine has since protected more than 150 million people in the United States, and its development method has also led to other vaccines that have protected billions of people around the world from polio, rabies, chicken pox, measles, hepatitis A, shingles, and adenovirus.

Host Dr. John Russell chats with Meredith Wadman, author of The Vaccine Race: Science, Politics, and the Human Costs of Defeating Disease, about the story of both the science of this urgent race and the political and ethical controversies that nearly ended it prematurely.

Host: Brian P. McDonough, MD, FAAFP

Over 33,000 lives were lost to opioid overdose in 2015, translating into 91 people dying each day, according to the most recent CDC data. Reducing exposure to prescription opioids, for situations where the risks of opioids outweigh their benefits, is a crucial part of reversing this trend.

Host Dr. Brian McDonough explores alternative options to prescription opioids with addiction specialist Dr. Isaac Alexis, Medical Director of the Lifeline Addiction Center in Beckley, WV.

Host: John Russell, MD

Revolutionary advances in medical knowledge have caused doctors to become so focused on their narrow fields of expertise that they often overlook the simplest fact of all: their patients are suffering.

Dr. John Russell welcomes Dr. Thomas Lee, Chief Medical Officer at Press Ganey and author of An Epidemic of Empathy in Healthcare: How to Deliver Compassionate, Connected Patient Care That Creates a Competitive Advantage. Their discussion focuses on the growing divide between world-class medical treatment and compassionate care, and why the two are not mutually exclusive.

Host: Shira Johnson, MD

Guest: Bennett Omalu, MD

Many studies have demonstrated long-lasting and even permanent brain damage that can originate from just one concussion. With athletes suffering multiple repeated head traumas due to high-contact sports, the controversies over player safety and long-term health risks remain hot-button issues.

Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for chronic traumatic encephalopathy after autopsying American football players. In this second of a two-part interview, he shares his perspectives on CTE in athletes and the lifelong dangers of contact sports.

Host: Shira Johnson, MD

Guest: Bennett Omalu, MD

Chronic Traumatic Encephalopathy (CTE) is a degenerative brain disease found in athletes, military veterans, and others who experience repetitive brain trauma. Pathologist Dr. Bennett Omalu coined the term "CTE" and published the first evidence for this condition after autopsying American football players.

Host Dr. Shira Johnson welcomes Dr. Omalu to share the story of his discovery and the medical, athletic, and public responses that followed.

Host: Shira Johnson, MD

Guest: Ronald DeMatteo, MD, FACS

A Gastrointestinal Stromal Tumor (GIST) is a rare sarcoma that begins in the digestive tract or stomach, with an incident rate in the United States of approximately 4,000 to 6,000 cases per year. Since these tumors behave differently from other gastrointestinal cancers, they require a specialized treatment plan.

Host Dr. Shira Johnson chats with Ronald DeMatteo, MD, FACS, Chair of the Department of Surgery and a surgical oncologist at Penn Medicine. They discuss the diagnosis, treatment and current clinical research of GIST. Dr. DeMatteo is a world-renowned surgical expert and researcher for the rare GIST. His research breakthroughs helped develop the new standard of care for GIST.

Host: Brian P. McDonough, MD, FAAFP

Exercise can improve your health and reduce the risk of developing several diseases such as type 2 diabetes, cancer, and cardiovascular disease.

Host Dr. Brian McDonough chats with veteran personal trainer and exercise therapy specialist Bobby Whisnand about ways to to keep your workout "working out" and how to avoid exercise pitfalls.

The FDA announced that it is requiring a new class warning and other safety measures for all gadolinium-based contrast agents (GBCAs) for magnetic resonance imaging (or MRI) concerning gadolinium remaining in patients’ bodies, including the brain, for months to years after receiving these drugs.

Report side effects involving GBCAs to FDA’s MedWatch program at www.fda.gov/medwatch.

A link to the full communication detailing specific information for health care professionals and a list of FDA approved GBCAs can be found at www.fda.gov/DrugSafety.

Released 12/19/2017

The FDA announced that a review of four large clinical safety trials shows that treating asthma with long-acting beta agonists (LABAs) in combination with inhaled corticosteroids (ICS) does not result in significantly more serious asthma-related side effects than treatment with ICS alone.

A link to the full communication detailing information for health care professionals and the Data Summary can be found at www.fda.gov/DrugSafetyCommunications.

Released 12/20/2017